11h
GlobalData on MSNNovartis reports Phase III efficacy and safety outcomes of SMA treatmentNovartis has reported positive efficacy and safety outcomes from its Phase III clinical programme for OAV101 IT (onasemnogene ...
Neurizon’s MD emphasised the company remained committed to advancing NUZ-001 as an effective potential treatment for amyotrophic lateral sclerosis/motor neurone disease (ALS/MND) and other ...
Using an unbiased approach, this important study discovered a role of Ezh2 in the differentiation of granule neuron precursors, the cell of origin for Shh group of medulloblastoma. Furthermore, the ...
In LRP4 disease, "false positives can be seen with motor neuron disease," he said. "I recommend always having neurophysiological testing and not making a diagnosis of myasthenia based only on the ...
3d
Stockhead on MSNNeurizon moves to lift FDA clinical hold on motor neurone drugNeurizon Therapeutics has submitted a formal request to the US FDA for advice on pharmacokinetic studies needed to lift hold ...
New Evrysdi five-year data from the SUNFISH study showed continued stabilisation of motor function in a broad population of ind ...
Barry Jones' life was thrown into turmoil when he was told he has motor neurone disease (MND), and roughly two years left to live. The pipe fitter from Milford Haven, Pembrokeshire, who tied the ...
This important study examined orientation representations along the visual hierarchy during perception and working memory. The authors provide results suggesting that during working memory there is a ...
While there is no cure for Motor Neurone Disease (MND), a clinical trial in Launceston aims to slow the disease and provide a ...
Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results